Learning science company McGraw-Hill Education today announced the launch of Redbird Language Arts & Writing, a new enhanced personalized learning program that helps students master language arts concepts and build strong foundational writing skills. The new program accomplishes this by combining innovative writing analysis technology, interactive practice and personalized learning. The supplemental curriculum, for grades 2-7 and at-risk secondary students, is available to U.S. schools nationwide.
Originally developed by Stanford University, Redbird’s adaptive learning technology provides a personalized learning experience for each student. Redbird Language Arts & Writing delivers immediate feedback and charts an optimized path through the program based on each individual student’s skillset and level of progress – while also empowering educators with real-time, data-driven insights about their students’ learning.
To view the multimedia release go to:
https://www.multivu.com/players/English/7782356-mcgraw-hill-education-redbird/
According to a recent survey, active adults aren’t slowing down. The survey found that 62 percent of adults ages 30-49 continue to work out as much – and with the same or more intensity – as they did in their 20s. More than half would like to ramp up their performance and do more of what they love, but are stopped by pain and the risk of injuries.
Massage Envy’s new, proprietary assisted stretching service, called Total Body Stretch, is designed to help people perform at their best, ease the muscle pain and tension that comes with activity, and resist injuries.
Developed for Massage Envy by an acclaimed chiropractor, massage therapist and ergonomist and performed by a stretching professional, the Total Body Stretch service is built around the company’s proprietary Streto Method, a sequence of 10 targeted stretches designed to increase flexibility, mobility and performance.
To view the multimedia release go to:
https://www.multivu.com/players/English/8133351-massage-envy-streto-total-body-stretch/
He lost her once. Is this their second chance? Transforming Belle Cove Resorts’ image will take Dakota Carson’s company to the next level, but it means working with the man who broke her heart. Years ago, Logan Montague walked away from everything, including the woman he loved. Now he’s back, and won’t risk losing Dakota again. Find out more at http://www.LisaWatson.com African American/Romance
To text or not to text? As, Valentine’s Day approaches, that is the question for the Romeos and Juliets of today’s digital world. Cricket Wireless commissioned a national survey1 to determine how people are beginning and ending relationships via mobile phone and to uncover lethal communication behaviors. According to the survey, 30 percent of Americans would ask someone out via text. Wooers must learn the digital courting code or risk suffering a tragic ending.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/56773-cricket-wireless-relationship-communication-survey-for-valentine-s-day
An international survey conducted by GSK and released for World Meningitis Day shows gaps in the knowledge parents feel they have about meningococcal disease and its potential consequences. Almost 7 in 10 parents said they don’t know enough about the different strains of meningococcal disease and the potential damage they can cause. On average, more than half of parents were either unsure or unaware that there are different types of bacteria that cause the disease.
The survey of 5,000 parents in Brazil, Canada, Germany, Italy and Portugal also shows that out of a list of 14 vaccine-preventable diseases, meningococcal disease is considered by many parents to pose a top three health risk to their children. Fifty-seven percent listed meningococcal disease among the top three health conditions they considered of greatest risk to children followed by Hepatitis B at 34 percent, pneumococcal disease at 27 percent, polio at 25 percent, tetanus at 20 percent and pertussis at 17 percent.
A sudden, potentially life-threatening illness, meningococcal disease kills on average one person every eight minutes worldwide. It typically manifests as bacterial meningitis – an infection of the membrane around the brain and spine; or bacteraemia – a bloodstream infection. The disease progresses rapidly and it can lead to death within 24-48 hours of the first symptoms; globally up to 1 in 10 of those infected may die and in the US about 10-15 percent of people will die.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7814851-gsk-survey-world-meningitis-day/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
New research from Carfax suggests that millions of people may be driving, buying, or selling potentially dangerous cars due to an unfixed recall. The company’s annual research on the issue shows more than 46 million cars nationwide have at least one safety recall that’s never been fixed. In fact, five million of them were bought and sold by potentially unsuspecting consumers in 2014.
One of the most alarming discoveries is that people driving or buying family-oriented vehicles – specifically minivans and SUVs – are most at risk. One in three minivans and one in five SUVs has an unfixed recall, according to Carfax.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7385551-carfax-unfixed-recall-data/
The American Kidney Fund today launches a national campaign to raise awareness about kidney disease, a serious and increasingly common condition that is damaging the health of as many as 31 million Americans. Pair Up: Join the Fight to Prevent Kidney Disease encourages women to take two simple, yet powerful actions: learn if they’re at risk for kidney disease; and spread the word about kidney disease to loved ones who also may be at risk. The launch of Pair Up coincides with the release of a national survey revealing that most Americans who care for their loved ones’ health are unaware that diabetes and high blood pressure are the leading causes of kidney disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51973-american-kidney-fund-laila-ali-pair-up-women-prevent-kidney-disease
Jewelry Television® (JTV) is showing support for the American Heart Association’s Go Red For Women® movement by launching “Love Your Heart,” a comprehensive, multimedia initiative aimed at raising awareness and educating viewers about the risks of heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60204-jewelry-television-jtv-love-your-heart-aha-go-red-for-women
Companies in every part of the nation sponsor tax-qualified benefit plans to attract and retain high quality employees. The plans are designed to offer employees tax relief as they build up their retirement through 401k plans or to buy medical and dental type benefits. However, according to EisnerAmper's Pension Services Group, tax relief that benefits both the employer and the plan participants is at risk of being lost if plan sponsors fail to follow basic qualification requirements by maintaining effective internal control structures over their plans.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7461932-eisneramper-employee-benefits/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
